You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AZD9150

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumours Trial in United States (AZD9150, Durvalumab, Cisplatin)

Active, not recruiting
  • Advanced Solid Tumours
  • AZD9150
  • +6 more
  • Lafayette, Indiana
  • +5 more
Jul 22, 2022

AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

Not yet recruiting
  • AML/MDS
  • +2 more
  • (no location specified)
Aug 14, 2023

HNSCC Trial (Danvatirsen, Pembrolizumab)

Not yet recruiting
  • HNSCC
  • (no location specified)
Apr 3, 2023

Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (AZD9150, MEDI4736, AZD5069)

Active, not recruiting
Has Results
  • Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck
  • AZD9150
  • +3 more
  • Birmingham, Alabama
  • +42 more
Oct 3, 2022

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston

Active, not recruiting
  • Advanced Colorectal Carcinoma
  • +24 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • AZD9150
  • +5 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)

Active, not recruiting
  • Muscle Invasive Bladder Cancer
  • Los Angeles, California
  • +26 more
Oct 17, 2022

Resectable, Early-stage, NSCLC Trial in Worldwide (Durvalumab, Oleclumab, Monalizumab)

Completed
Has Results
  • Resectable
  • +2 more
  • La Jolla, California
  • +17 more
Feb 23, 2022

Metastatic NSCLC (NSCLC) Trial in Worldwide (Durvalumab, Danvatirsen, Oleclumab)

Active, not recruiting
  • Metastatic Non-Small Cell Lung Cancer (NSCLC)
  • Iowa City, Iowa
  • +45 more
Jan 13, 2023

Advanced Solid Malignancies Trial in Kashiwa, Matsuyama-shi (AZD9150, Durvalumab)

Completed
  • Advanced Solid Malignancies
  • AZD9150, Durvalumab
  • Kashiwa, Japan
  • +1 more
Jun 21, 2019

DLBCL Trial in Worldwide (MEDI4736, tremelimumab, AZD9150)

Completed
  • Diffuse Large B-Cell Lymphoma
  • La Jolla, California
  • +12 more
Feb 26, 2019

Heart Failure Trial in Finland, Germany, Netherlands (AZD8601, Placebo)

Completed
  • Heart Failure
  • Kuopio, Finland
  • +5 more
Aug 4, 2021

Male Subjects With Type II Diabetes (T2DM) Trial in Berlin (AZD8601+Placebo (SAD), AZD8601+Placebo, Placebo+Placebo)

Completed
  • Male Subjects With Type II Diabetes (T2DM)
  • AZD8601+Placebo (SAD)
  • +2 more
  • Berlin, Germany
    Research Site
Jan 15, 2020

Ovarian Cancer, Ovarian Tumors, Ascites Trial run by the NCI (AZD9150)

Terminated
Has Results
  • Ovarian Cancer
  • +4 more
  • AZD9150
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 5, 2017

Advanced Adult Hepatocellular Carcinoma, Hepatocellular Carcinoma Metastatic Trial in Worldwide (AZD9150)

Completed
Has Results
  • Advanced Adult Hepatocellular Carcinoma
  • Hepatocellular Carcinoma Metastatic
  • AZD9150
  • Hongkong, Hong Kong
  • +6 more
Jan 13, 2017